Initial Screening for Inflammatory Bowel Disease
For patients aged 16-40 presenting with chronic lower gastrointestinal symptoms lasting >4 weeks, measure faecal calprotectin alongside basic laboratory tests, and refer urgently to gastroenterology for ileocolonoscopy if calprotectin is >250 μg/g. 1, 2
Primary Care Assessment
Essential History Components
- Stool characteristics: frequency, consistency, presence of blood or mucus, urgency, nocturnal symptoms 1, 2
- Systemic symptoms: fever, weight loss, malaise, fatigue 1, 2, 3
- Red flag features: rectal bleeding with abdominal pain, change in bowel habit, iron deficiency anemia, abdominal/rectal/anal mass, unexplained anal ulceration 1, 2
- Medication history: recent NSAID use (affects calprotectin interpretation), antibiotics, recent travel 1, 2
- Smoking status and family history of IBD 1, 2
- Extraintestinal manifestations: joint pain, skin changes, eye symptoms 1, 2
Physical Examination Findings
- Vital signs: pulse rate (tachycardia suggests severe disease), blood pressure (hypotension indicates volume depletion), temperature (fever suggests complications), weight (compare to baseline) 1, 2
- General appearance: assess for anemia, fluid depletion 1, 2
- Abdominal examination: tenderness, distension, palpable masses 1, 2
- Rectal examination: inspect for perianal disease, anal ulceration, masses 1, 2
Mandatory Initial Laboratory Testing
All patients must have the following tests in primary care: 1, 2
- Complete blood count (assess for anemia, leukocytosis) 1, 2
- Urea and electrolytes 1, 2
- C-reactive protein (CRP) 1, 2
- Coeliac serology 1, 2
- Stool culture including Clostridium difficile toxin 1, 2
Faecal Calprotectin Interpretation and Action
Do not perform calprotectin testing if NSAID use within the past 6 weeks. 1
Calprotectin <100 μg/g
- IBS is likely; treat as IBS in primary care 1
- Consider other diagnoses if symptoms persist: bile acid malabsorption, microscopic colitis, medication effects 1
- If IBD remains strongly suspected based on clinical features or family history, refer to gastroenterology despite low calprotectin 1, 2
Calprotectin 100-250 μg/g
- Consider repeat testing or routine referral to gastroenterology 1
- If strong clinical suspicion exists (red flag features, family history), proceed with urgent referral regardless of intermediate values 1, 2
- This intermediate range is challenging to interpret as mild elevation may reflect non-specific low-grade inflammation 1
Calprotectin >250 μg/g
- Refer urgently to gastroenterology for ileocolonoscopy 1, 2
- Exclude infectious causes before referral 1
Critical Pitfalls to Avoid
- Do not rely on CRP alone: approximately 15-20% of patients with active IBD have normal CRP levels 1, 2
- Do not defer colonoscopy based on intermediate calprotectin if clinical suspicion is high: calprotectin should be interpreted in light of pre-test probability 1, 2
- Do not delay assessment if systemically unwell: patients with suspected acute severe colitis require urgent inpatient assessment regardless of test results 1
- Do not ignore red flag features: rectal bleeding with abdominal pain, unexplained weight loss, or palpable masses warrant immediate cancer pathway referral per NICE guidelines 1
Calprotectin Sampling Technique
Use the first stool passed in the morning and store for no more than 3 days at room temperature before analysis to minimize variation in calprotectin levels. 1
Secondary Care Diagnostic Workup
Once referred to gastroenterology:
Endoscopic Evaluation
- Ileocolonoscopy with terminal ileal intubation is the reference standard 1, 2
- Multiple biopsies from affected and normal-appearing areas, including terminal ileum 1, 2
- For suspected Crohn's disease: document focal, asymmetric inflammation and skip lesions 1, 2
- For ulcerative colitis: assess disease extent, look for loss of vascular pattern, granularity, friability, ulceration 1, 2
Cross-Sectional Imaging
- MR enterography is essential at diagnosis to assess small bowel involvement and detect complications in Crohn's disease 2